Long-term control of Paget ’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting
ConclusionIn a large proportion of “real world” PDB patients, remission can be achieved with once-weekly, “osteoporosis doses” of alendronate or risedronate.
Source: Endocrine - Category: Endocrinology Source Type: research
More News: Academia | Actonel | Endocrinology | Orthopaedics | Osteoporosis | Paget's Disease | Reclast | Risedronate | Zometa